CXCL8 and gout: The CXCL9(74–103) peptide competed with the most potent human neutrophil-attracting chemokine, i.e., CXCL8 for GAG binding and blocked neutrophil migration in both a gout model and an inflammation model that involved intra-articular injection with CXCL8 (231).